Clinical Trial Update: Tardive Dyskinesia and Cognitive Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Taipei Veterans General Hospital indicates the study examining tardive dyskinesia and neurocognitive function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Tardive Dyskinesia, Neurocognitive Function | Phase 4 | Status: COMPLETED